The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Multi-site Decision Impact Study for Decipher
Official Title: ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Study ID: NCT02034825
Brief Summary: This prospectively designed retrospective clinical utility study will evaluate urologists' treatment recommendations before and after reviewing Decipher results for selected patient cases.
Detailed Description: The clinical utility of Decipher will be evaluated at two time-points: 1. Post RP - within 6 months after surgery 2. PSA rise - defined as PSA detectable and rising on 2 or more subsequent determinations Patient cases will be retrospectively selected from at least 5 sites. Participating urologists at each site will be asked to each identify a minimum of 10 to a maximum of 50 suitable cases retrospectively. The resulting cases will then be de-identified, aggregated and evenly randomly distributed among the participating urologists via a secure on-line survey platform . All study participants (ie: urologists) will be masked to the original actual treatment decision and patient outcome. The design of this study is such that any participating urologist may or may not review a patient originating from their own clinical practice, but will not review a case they themselves identified. Patient cases will be de-identified and randomized amongst participating urologists . By the retrospective nature of this study, cases may be several years post-RP. It is not expected that that participation in this study will have any impact on actual clinical management of patients. Participants will be asked to complete two web-based electronic Case Report Questionnaires (eCRQ): 1. Pre-Decipher: will collect information on their recommended treatment decision and their decision confidence based on the de-identified clinical and pathological information provided for each patient case. 2. Post-Decipher: will collect their treatment recommendation and decision confidence for each de-identified patient case in the presence of the Decipher test results.
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Cedar Associates LLC, Menlo Park, California, United States
Florida Hospital, Celebration, Florida, United States
Columbia University, New York, New York, United States
Name: Badani K Ketan, MD
Affiliation: Columbia University
Role: PRINCIPAL_INVESTIGATOR
Name: Christine d Buerki, PhD
Affiliation: GenomeDx Biosciences Inc.
Role: STUDY_DIRECTOR
Name: Vipul Patel, MD
Affiliation: AdventHealth
Role: PRINCIPAL_INVESTIGATOR